FFT Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$589K Sell
4,609
-61
-1% -$7.62K 0.11% 65
2025
Q4
$569K Sell
4,670
-365
-7% -$41.9K 0.11% 58
2025
Q3
$505K Hold
5,035
0.09% 68
2025
Q2
$430K Sell
5,035
-7,240
-59% -$578K 0.08% 73
2025
Q1
$996K Sell
12,275
-4,816
-28% -$430K 0.21% 51
2024
Q4
$1.54M Sell
17,091
-1,025
-6% -$99.3K 0.12% 51
2024
Q3
$1.79M Sell
18,116
-2,763
-13% -$271K 0.14% 49
2024
Q2
$1.94M Sell
20,879
-1,511
-7% -$135K 0.17% 43
2024
Q1
$2.12M Sell
22,390
-685
-3% -$63.6K 0.18% 42
2023
Q4
$2.06M Sell
23,075
-882
-4% -$65.5K 0.18% 37
2023
Q3
$1.75M Sell
23,957
-1,762
-7% -$141K 0.23% 31
2023
Q2
$2.14M Sell
25,719
-17,405
-40% -$1.46M 0.27% 28
2023
Q1
$3.29M Sell
43,124
-8,084
-16% -$671K 0.41% 25
2022
Q4
$4.25M Buy
51,208
+7,467
+17% +$605K 0.55% 25
2022
Q3
$3.47M Buy
43,741
+6,799
+18% +$573K 0.48% 21
2022
Q2
$2.74M Buy
36,942
+31,915
+635% +$2.4M 0.31% 25
2022
Q1
$452K Buy
+5,027
New +$464K 0.04% 40

Other funds holding XBI